323 related articles for article (PubMed ID: 32883290)
21. A study of concurrent radiochemotherapy with paclitaxel in glioblastoma multiforme.
Julka PK; Awasthy BS; Rath GK; Agarwal S; Varna T; Mahapatra AK; Singh R
Australas Radiol; 2000 Feb; 44(1):84-7. PubMed ID: 10761264
[TBL] [Abstract][Full Text] [Related]
22. [Radiation therapy for brain tumors].
Tanaka Y; Fujii M; Saito T; Kawamori J
Nihon Igaku Hoshasen Gakkai Zasshi; 2004 Sep; 64(7):387-93. PubMed ID: 15688744
[TBL] [Abstract][Full Text] [Related]
23. Application of High-Z Nanoparticles to Enhance Current Radiotherapy Treatment.
Jackson N; Cecchi D; Beckham W; Chithrani DB
Molecules; 2024 May; 29(11):. PubMed ID: 38893315
[TBL] [Abstract][Full Text] [Related]
24. The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.
Pepper NB; Stummer W; Eich HT
Strahlenther Onkol; 2022 Jun; 198(6):507-526. PubMed ID: 35503461
[TBL] [Abstract][Full Text] [Related]
25. Radiosensitizing Fe-Au nanocapsules (hybridosomes®) increase survival of GL261 brain tumor-bearing mice treated by radiotherapy.
Goubault C; Jarry U; Bostoën M; Éliat PA; Kahn ML; Pedeux R; Guillaudeux T; Gauffre F; Chevance S
Nanomedicine; 2022 Feb; 40():102499. PubMed ID: 34843982
[TBL] [Abstract][Full Text] [Related]
26. Theranostic nanoparticles enhance the response of glioblastomas to radiation.
Wu W; Klockow JL; Mohanty S; Ku KS; Aghighi M; Melemenidis S; Chen Z; Li K; Morais GR; Zhao N; Schlegel J; Graves EE; Rao J; Loadman PM; Falconer RA; Mukherjee S; Chin FT; Daldrup-Link HE
Nanotheranostics; 2019; 3(4):299-310. PubMed ID: 31723547
[TBL] [Abstract][Full Text] [Related]
27. Gallic acid-gold nanoparticles enhance radiation-induced cell death of human glioma U251 cells.
Jing Z; Li M; Wang H; Yang Z; Zhou S; Ma J; Meng E; Zhang H; Liang W; Hu W; Wang X; Fu X
IUBMB Life; 2021 Feb; 73(2):398-407. PubMed ID: 33372372
[TBL] [Abstract][Full Text] [Related]
28. Role of radiation therapy and radiosurgery in glioblastoma multiforme.
Fiveash JB; Spencer SA
Cancer J; 2003; 9(3):222-9. PubMed ID: 12952307
[TBL] [Abstract][Full Text] [Related]
29. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
Hoshino T
Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
[No Abstract] [Full Text] [Related]
30. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
[TBL] [Abstract][Full Text] [Related]
31. DTCM-glutarimide Delays Growth and Radiosensitizes Glioblastoma.
Roberto GM; Paiva HH; Botelho de Souza LE; Pezuk JA; Vieira GM; de Oliveira HF; Umezawa K; Tone LG; Brassesco MS
Anticancer Agents Med Chem; 2018; 18(9):1323-1329. PubMed ID: 29683097
[TBL] [Abstract][Full Text] [Related]
32. Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.
Pinel S; Thomas N; Boura C; Barberi-Heyob M
Adv Drug Deliv Rev; 2019 Jan; 138():344-357. PubMed ID: 30414495
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3.
Ventero MP; Fuentes-Baile M; Quereda C; Perez-Valeciano E; Alenda C; Garcia-Morales P; Esposito D; Dorado P; Manuel Barbera V; Saceda M
PLoS One; 2019; 14(2):e0212581. PubMed ID: 30811476
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity, dose-enhancement and radiosensitization of glioblastoma cells with rare earth nanoparticles.
Lu VM; Crawshay-Williams F; White B; Elliot A; Hill MA; Townley HE
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):132-143. PubMed ID: 30663430
[TBL] [Abstract][Full Text] [Related]
35. Berberine sensitizes human glioma cells, but not normal glial cells, to ionizing radiation in vitro.
Yount G; Qian Y; Moore D; Basila D; West J; Aldape K; Arvold N; Shalev N; Haas-Kogan D
J Exp Ther Oncol; 2004 Jul; 4(2):137-43. PubMed ID: 15500008
[TBL] [Abstract][Full Text] [Related]
36. Advances in translational research provide a rationale for clinical re-evaluation of high-dose radiotherapy for glioblastoma.
Nieder C; Mehta MP
Med Hypotheses; 2011 Mar; 76(3):410-3. PubMed ID: 21112157
[TBL] [Abstract][Full Text] [Related]
37. Hypofractionated accelerated radiotherapy (HART) with concurrent and adjuvant temozolomide in newly diagnosed glioblastoma: a phase II randomized trial (HART-GBM trial).
Mallick S; Kunhiparambath H; Gupta S; Benson R; Sharma S; Laviraj MA; Upadhyay AD; Julka PK; Sharma D; Rath GK
J Neurooncol; 2018 Oct; 140(1):75-82. PubMed ID: 29936695
[TBL] [Abstract][Full Text] [Related]
38. FOXM1 and STAT3 interaction confers radioresistance in glioblastoma cells.
Maachani UB; Shankavaram U; Kramp T; Tofilon PJ; Camphausen K; Tandle AT
Oncotarget; 2016 Nov; 7(47):77365-77377. PubMed ID: 27764801
[TBL] [Abstract][Full Text] [Related]
39. Critical parameters to translate gold nanoparticles as radiosensitizing agents into the clinic.
Moloudi K; Khani A; Najafi M; Azmoonfar R; Azizi M; Nekounam H; Sobhani M; Laurent S; Samadian H
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(6):e1886. PubMed ID: 36987630
[TBL] [Abstract][Full Text] [Related]
40. Radiosensitizing effects of temozolomide observed in vivo only in a subset of O6-methylguanine-DNA methyltransferase methylated glioblastoma multiforme xenografts.
Carlson BL; Grogan PT; Mladek AC; Schroeder MA; Kitange GJ; Decker PA; Giannini C; Wu W; Ballman KA; James CD; Sarkaria JN
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):212-9. PubMed ID: 19695438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
